$5.02
0[0.00%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$5.0008
-0.0192[-0.38%]
| Open- | Close- |
| Vol / Avg.0 / 29.220K | Mkt Cap19.268M |
| Day Range- - - | 52 Wk Range5.000 - 23.854 |
Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Key Statistics
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) analysis, key statistics.
Valuation Measures
Enterprise Value
-30.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.78
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-237.45%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
6.43
Tangible Book value per share
5.6
Total Liabilities (Quarterly)
10.1M
Total Assets
36.5M
Total Liabilities
10.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Key Statistics
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) analysis, key statistics.
Valuation Measures
Enterprise Value
-30.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.78
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-237.45%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
6.43
Tangible Book value per share
5.6
Total Liabilities (Quarterly)
10.1M
Total Assets
36.5M
Total Liabilities
10.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Key Statistics
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) analysis, key statistics.
Valuation Measures
Enterprise Value
-30.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.78
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-237.45%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
6.43
Tangible Book value per share
5.6
Total Liabilities (Quarterly)
10.1M
Total Assets
36.5M
Total Liabilities
10.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Key Statistics
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) analysis, key statistics.
Valuation Measures
Enterprise Value
-30.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.78
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-237.45%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
6.43
Tangible Book value per share
5.6
Total Liabilities (Quarterly)
10.1M
Total Assets
36.5M
Total Liabilities
10.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Key Statistics
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) analysis, key statistics.
Valuation Measures
Enterprise Value
-30.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.78
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-237.45%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
6.43
Tangible Book value per share
5.6
Total Liabilities (Quarterly)
10.1M
Total Assets
36.5M
Total Liabilities
10.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Key Statistics
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) analysis, key statistics.
Valuation Measures
Enterprise Value
-30.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.78
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-237.45%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
6.43
Tangible Book value per share
5.6
Total Liabilities (Quarterly)
10.1M
Total Assets
36.5M
Total Liabilities
10.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Key Statistics
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) analysis, key statistics.
Valuation Measures
Enterprise Value
-30.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.78
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-237.45%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
6.43
Tangible Book value per share
5.6
Total Liabilities (Quarterly)
10.1M
Total Assets
36.5M
Total Liabilities
10.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Key Statistics
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) analysis, key statistics.
Valuation Measures
Enterprise Value
-30.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.78
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-237.45%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
6.43
Tangible Book value per share
5.6
Total Liabilities (Quarterly)
10.1M
Total Assets
36.5M
Total Liabilities
10.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Key Statistics
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) analysis, key statistics.
Valuation Measures
Enterprise Value
-30.2M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.78
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-237.45%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
6.43
Tangible Book value per share
5.6
Total Liabilities (Quarterly)
10.1M
Total Assets
36.5M
Total Liabilities
10.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -